Literature DB >> 7524745

Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells.

R Pettengell1, T Luft, R Henschler, J M Hows, T M Dexter, D Ryder, N G Testa.   

Abstract

Limiting-dilution analysis of long-term culture-initiating cells (LTCIC) is a quantitative method of estimating hematopoietic stem cell activity in clinical samples. We compared the numbers of LTCIC in bone marrow (BM), umbilical cord blood, and blood progenitor cells (obtained from patients with solid tumors at leukapheresis after mobilization with induction chemotherapy and filgrastim administration), using a two-stage long-term culture system and a limiting-dilution technique, scoring cobblestone areas of greater than 15 hematopoietic cells weekly for up to 8 weeks. Samples were obtained from 30 normal BMs, 20 human umbilical cords, and 32 leukapheresis products. Direct comparison of LTCIC in the three sources showed that the median proportions of cells generating hematopoietic foci from unfractionated mononuclear cells at 5 and 8 weeks, respectively, were 1:13,314 and 1:33,949 for BM, 1:12,506 and 1:34,546 for umbilical cord blood, and 1:10,302 and 1:12,891 for leukapheresis product. The estimated proportions of LTCIC from unfractionated mononuclear cells and CD34+ cells were similar in experiments with leukapheresis product. Leukapheresis product was superior to umbilical cord blood and cord blood to BM at 5 and 8 weeks of culture (P = .01). In two-stage long-term cultures, more colonies per flask and CD34+ cells were found in assays of leukapheresis product than in BM or umbilical cord blood cultures (P = .0005). Results obtained by this simplified limiting-dilution analysis correlated well with standard long-term cultures and can be used as a measure of the stem cell population. These data suggest that the incidence of putative stem cells in leukapheresis product and umbilical cord blood are at least comparable with that of BM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524745

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine.

Authors:  Patricia Flores-Guzmán; Verónica Fernández-Sánchez; Hector Mayani
Journal:  Stem Cells Transl Med       Date:  2013-10-07       Impact factor: 6.940

Review 2.  Autologous peripheral blood stem cells: collection and processing.

Authors:  M Hansson; A Svensson; P Engervall
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

3.  Human fetal liver cells induce colonies in spleen of lethally irradiated mice.

Authors:  F Rezzoug; A Tocci; K Safsafi; G Vivier; J L Touraine
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

4.  A stochastic model for cancer stem cell origin in metastatic colon cancer.

Authors:  Christine Odoux; Helene Fohrer; Toshitaka Hoppo; Lynda Guzik; Donna Beer Stolz; Dale W Lewis; Susanne M Gollin; T Clark Gamblin; David A Geller; Eric Lagasse
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

Review 5.  AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders.

Authors:  Sharmin Esmailzadeh; Xiaoyan Jiang
Journal:  Oncotarget       Date:  2011-12

6.  Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer.

Authors:  P Pedrazzoli; C Perotti; G A Da Prada; F Bertolini; N Gibelli; L Torretta; M Battaglia; L Pavesi; P Preti; L Salvaneschi; G Robustelli della Cuna
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 7.  Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.

Authors:  R E Parchment
Journal:  Environ Health Perspect       Date:  1998-04       Impact factor: 9.031

8.  Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells.

Authors:  Michele Massimino; Paolo Vigneri; Stefania Stella; Elena Tirrò; Maria Stella Pennisi; Laura Nunziatina Parrinello; Calogero Vetro; Livia Manzella; Fabio Stagno; Francesco Di Raimondo
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

9.  Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1.

Authors:  C E Müller-Sieburg; R Riblet
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Mononuclear cells from the cord blood and granulocytecolony stimulating factor-mobilized peripheral blood: is there a potential for treatment of cerebral palsy?

Authors:  Hani Koh; Kyoujung Hwang; Hae-Young Lim; Yong-Joo Kim; Young-Ho Lee
Journal:  Neural Regen Res       Date:  2015-12       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.